LeafNLP Demos
Back to explore

Report #2878388

Received Dec 17, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
60 yrs
State
IL
Recovered
Unknown
Vaccinated
Dec 15, 2025
Onset
Dec 15, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKGJ952—

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

Shingrix administered ventrogluteal instead on the deltoid; This non-serious case was reported by a other health professional via call center representative and described the occurrence of vaccine administered at inappropriate site in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number GJ952, expiry date 25-APR-2027) for prophylaxis. On 15-DEC-2025, the patient received Shingrix. On 15-DEC-2025, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: Shingrix administered ventrogluteal instead on the deltoid). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 15-DEC-2025 The vaccine administration facility was the same as primary reporter.